Aurobindo receives FDA OK for generic Furadantin

Aurobindo has received the green light from the Food and Drug Administration for nitrofurantoin oral suspension 25 mg/5 ml, which is the generic of Casper Pharma’s Furadantin.
Nitrofurantoin oral suspension is indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus and certain susceptible strains of Klebsiella and Enterobacter species.
Nitrofurantoin oral suspension has a market value of roughly $55 million for the 12 months ending March 2023, per IQVIA.
Source: Drugstorenews

Gubba Group

About the author

Gubba Group: